Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Web3
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
DeFi Giant Spark Shelves Crypto App P
Web3
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
DeFi Giant Spark Shelves Crypto App P
DeFi Giant Spark Shelves Crypto App Plans to Focus on Institutional Infrastructure
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
DeFi Giant Spark Shelves Crypto App Plans to Focus on Institutional Infrastructure
The protocol will instead focus on "liquidity infrastructure and deals" such as its recent $1 billion investment into PayPal's PYUSD.
By Francisco Rodrigues|Edited by Nikhilesh De
Nov 19, 2025, 9:34 p.m.
(Sajad Nori/Unsplash/Modified by CoinDesk)
What to know:
- DeFi protocol Spark has paused plans to launch a mobile app, citing a focus on its core competency in DeFi-native crypto and a competitive market.
- The protocol will instead focus on "liquidity infrastructure and deals" such as its recent $1B investment into PayPal's PYUSD, targeting institutional use cases.
- The decision comes as another DeFi giant, Aave, has announced the launch of a retail yield app, with Spark's CEO expressing well-wishes but also highlighting the competitive nature of the market.
Decentralized finance (DeFi) giant Spark has shelved its plans to launch a mobile app, for now.
“We had an internal discussion and we’re going to put it on pause for now just because we view our edge as largely in the DeFi-native crypto space,” Sam MacPherson, CEO of Phoenix Labs, told CoinDesk in an interview during Devconnect Buenos Aires. “We are not builders of consumer apps, and this space is very competitive.”
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the The Protocol Newsletter today. See all newsletters
Sign me up
Phoenix Labs is the company behind the development of the Spark protocol, which to date has amassed over $9 billion in total value locked, according to data from DeFiLlama.
“If and when we do go in, we need to be certain we have some sort of edge there. I think there's a tendency for projects to get distracted doing too many things at once,” MacPherson said. “So we're going to just double down on what we do best, which is liquid infrastructure within DeFi."
The protocol will instead focus on what MacPherson called “liquidity infrastructure and deals like our recent $1 billion investment with our own balance sheet into PYUSD with PayPal,” pointing to a focus on institutional use cases rather than the creation of more retail-friendly solutions. He was referencing a $1 billion investment intended to scale up PYUSD's liquidity.
When asked whether the mobile app had been canceled or just delayed, MacPherson said it’s “paused for now. Things can change, but it's about the market; you've got to see opportunities, and it's just not there right now for us."
MacPherson’s words come shortly after another DeFi giant, Aave, announced the launch of a retail yield app. “It’s an exciting development, but as I said, it's a competitive environment. I wish them the best of luck,” MacPherson said when asked about the launch.
Spark protocolExclusive
More For You
Protocol Research: GoPlus Security
Commissioned byGoPlus
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
View Full Report
More For You
1inch Unveils Protocol Letting Multiple DeFi Strategies Share the Same Capital
Aqua introduces a "shared liquidity layer" that enables capital from a single wallet to back multiple trading strategies simultaneously.
What to know:
- 1inch has unveiled Aqua, a new liquidity protocol that allows DeFi applications to share a single capital base across multiple strategies without compromising user custody.
- Aqua introduces a "shared liquidity layer" that enables capital from a single wallet to back multiple trading strategies simultaneously.
- The protocol allows liquidity providers to authorize their tokens for multiple strategies, operating with their own rules and access limits, and enables users to use their assets across multiple DeFi roles, such as providing liquidity, voting, or posting collateral.
Read full story
Latest Crypto News
Nvidia Earnings Beat, Strong Outlook Calm Jittery Markets; Bitcoin Re-Takes $90K
Trump's Pick to Run CFTC, Selig, Tells Senators Crypto a 'Critical Mission' at Agency
Fed Rate Cut Odds Plunge Further on Jobs Data Delays
New Hampshire Awaits Bitcoin Bond Buyer to Get First State Effort Rolling
Crypto Leverage Hits Record High in Q3 as DeFi Dominance Reshapes Market Structure: Galaxy
AI Agents Need Identity and Zero-Knowledge Proofs Are the Solution
Top Stories
Nvidia Earnings Beat, Strong Outlook Calm Jittery Markets; Bitcoin Re-Takes $90K
Fed Rate Cut Odds Plunge Further on Jobs Data Delays
Trump's Pick to Run CFTC, Selig, Tells Senators Crypto a 'Critical Mission' at Agency
Crypto Leverage Hits Record High in Q3 as DeFi Dominance Reshapes Market Structure: Galaxy
Bitcoin Slips Back Below $90K — Crypto Correction Now Ranks Among Worst Since 2017, K33 Says
New Hampshire Awaits Bitcoin Bond Buyer to Get First State Effort Rolling
Market Opportunity
DeFi Price(DEFI)
$0,000356
$0,000356$0,000356
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You
Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?
The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09